Showing results (491-500 of 631) with videos related to

Sort By:
Pageof 64
The Journal of Clinical Investigation|August 14, 2019
AAV8-vectored suprachoroidal gene transfer produces widespread ocular transgene expressionKun Ding, Jikui Shen, Zibran Hafiz, et al.
European Journal of Internal Medicine|June 3, 2020
Efficacy and safety of tocilizumab in severe COVID-19 patients: a single-centre retrospective cohort studyCorrado Campochiaro, Emanuel Della-Torre, Giulio Cavalli, et al.
Annals of the Rheumatic Diseases|July 7, 2021
Molecular basis for clinical diversity between autoantibody subsets in diffuse cutaneous systemic sclerosisKristina Elizabeth Neergaard Clark, Corrado Campochiaro, Eszter Csomor, et al.
Ophthalmology|June 26, 2012
Sustained delivery fluocinolone acetonide vitreous inserts provide benefit for at least 3 years in patients with diabetic macular edemaPeter A Campochiaro, David M Brown, Andrew Pearson, et al.
Ophthalmology|April 5, 2019
The Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration: Results from the Randomized Phase 2 Ladder Clinical TrialPeter A Campochiaro, Dennis M Marcus, Carl C Awh, et al.
Ophthalmology|May 15, 2015
Scatter Photocoagulation Does Not Reduce Macular Edema or Treatment Burden in Patients with Retinal Vein Occlusion: The RELATE TrialPeter A Campochiaro, Gulnar Hafiz, Tahreem A Mir, et al.
American Journal of Cardiovascular Disease|March 25, 2017
Long-term clinical outcomes of patients with rheumatoid arthritis and concomitant coronary artery diseaseMarco Spartera, Cosmo Godino, Elena Baldissera, et al.
American Journal of Ophthalmology|July 15, 2023
Exudation in Patients With Neovascular Age-Related Macular Degeneration Treated With the Port Delivery System or Monthly InjectionsAnam Akhlaq, David Williams, W Lloyd Clark, et al.
Lancet (London, England)|May 21, 2017
Intravitreous injection of AAV2-sFLT01 in patients with advanced neovascular age-related macular degeneration: a phase 1, open-label trialJeffrey S Heier, Saleema Kherani, Shilpa Desai, et al.
Biomaterials|March 16, 2020
Sustained delivery of acriflavine from the suprachoroidal space provides long term suppression of choroidal neovascularizationSean F Hackett, Jie Fu, Yoo Chun Kim, et al.
Pageof 64